Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126063971 | 12606397 | 1 | I | 20160719 | 20160729 | 20160729 | EXP | GB-GLAXOSMITHKLINE-GB2016GSK108175 | GLAXOSMITHKLINE | ROBERTS RM, MUKHERJEE J, PHILLIPS D. LARYNGEAL LEISHMANIASIS IN A PATIENT TAKING INHALED CORTICOSTEROIDS. BMJ CASE REPORTS. 2016;1-2 | 0.00 | E | M | Y | 0.00000 | 20160729 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126063971 | 12606397 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | Y | U | 21254 | ||||||||
| 126063971 | 12606397 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | Y | U | 21254 | ||||||||
| 126063971 | 12606397 | 3 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 126063971 | 12606397 | 4 | C | Tiotropium | TIOTROPIUM | 1 | 0 | ||||||||||||
| 126063971 | 12606397 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126063971 | 12606397 | 1 | Asthma |
| 126063971 | 12606397 | 3 | Product used for unknown indication |
| 126063971 | 12606397 | 4 | Product used for unknown indication |
| 126063971 | 12606397 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126063971 | 12606397 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126063971 | 12606397 | Condition aggravated | |
| 126063971 | 12606397 | Dysphonia | |
| 126063971 | 12606397 | Immunosuppression | |
| 126063971 | 12606397 | Laryngeal oedema | |
| 126063971 | 12606397 | Laryngeal ulceration | |
| 126063971 | 12606397 | Leishmaniasis | |
| 126063971 | 12606397 | Oropharyngeal candidiasis | |
| 126063971 | 12606397 | Oropharyngeal plaque | |
| 126063971 | 12606397 | Pseudomonas infection | |
| 126063971 | 12606397 | Tracheal inflammation | |
| 126063971 | 12606397 | Vocal cord cyst |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |